Showing results (341-350 of 436) with videos related to

Sort By:
Pageof 44
Pediatric Blood & Cancer|May 18, 2026
Pharmacokinetics, Efficacy, and Safety Profiles of Mitoxantrone Hydrochloride Liposome Plus Cytarabine in Pediatric Patients With Newly Diagnosed Acute Myeloid LeukemiaWenyu Yang, Ranran Zhang, Xiaolan Li, et al.
Nature Communications|May 30, 2026
Inference of upstream-mutation and metabolomic-signature causality identifies prognostic biomarkers and therapeutic targets in pancreatic cancerFeng Chen, Xiaoying Lou, Xingting Guo, et al.
Zhongguo Dang Dai Er Ke Za Zhi = Chinese Journal of Contemporary Pediatrics|April 22, 2020
[Clinical effect of two different regimens in treatment of acute lymphoblastic leukemia children with bone marrow recurrence]Bei-Bei Zhao, Xiao-Juan Chen, Ye Guo, et al.
Aging|December 8, 2020
The adhesion molecule ICAM-1 in diffuse large B-cell lymphoma post-rituximab era: relationship with prognostic importance and rituximab resistanceYizhen Liu, Juan J Gu, Ling Yang, et al.
Cancer Medicine|December 31, 2020
Relmacabtagene autoleucel (relma-cel) CD19 CAR-T therapy for adults with heavily pretreated relapsed/refractory large B-cell lymphoma in ChinaZhitao Ying, Haiyan Yang, Ye Guo, et al.
Zhongguo Dang Dai Er Ke Za Zhi = Chinese Journal of Contemporary Pediatrics|August 17, 2019
[Clinical features and prognosis of children with acute lymphoblastic leukemia and different platelet levels]Ao-Li Zhang, Xiao-Juan Chen, Yao Zou, et al.
Cancer Letters|June 6, 2024
Single-cell transcriptomic analysis of the immune microenvironment in pediatric acute leukemiaJiapei Yuan, Jingliao Zhang, Beibei Zhao, et al.
Hypertension (Dallas, Tex. : 1979)|September 20, 2021
Prevalence and Risk Factors for Hypertension in Adolescents Aged 12 to 17 Years: A School-Based Study in ChinaKai Liu, Chen Li, Haibin Gong, et al.
Oncotarget|April 16, 2016
Cardiotoxicity as indicated by LVEF and troponin T sensitivity following two anthracycline-based regimens in lymphoma: Results from a randomized prospective clinical trialKai Xue, Juan J Gu, Qunling Zhang, et al.
Journal for Immunotherapy of Cancer|June 1, 2023
Phase I trial of KN046, a novel bispecific antibody targeting PD-L1 and CTLA-4 in patients with advanced solid tumorsYuxiang Ma, Jinhui Xue, Yuanyuan Zhao, et al.
Pageof 44